Your browser doesn't support javascript.
loading
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.
Pouyiourou, M; Meyer, A; Stroux, A; Viardot, A; La Rosée, P; Maschmeyer, G; Kämpfe, D; Kahl, C; Vucinic, V; Monecke, A; Hirt, C; Weber, T; Meissner, J; Witzens-Harig, M; Böttcher, S; Schmalenberg, H; Marks, R; Prange-Krex, G; Kroschinsky, F; Hauf, E; Keller, U; Koch, K; Klapper, W; Herold, M; Scholz, Christian W.
Afiliação
  • Pouyiourou M; Department of Hematology, Oncology and Rheumatology, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Meyer A; Department of Hematology and Oncology, Vivantes Klinikum Am Urban, Dieffenbachstraße 1, 10967, Berlin, Germany.
  • Stroux A; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Viardot A; Institut for Medical Biometrics and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • La Rosée P; Department of Hematology, Oncology, Palliative Care, Rheumatology and Infectious Diseases, Universitätsklinikum Ulm, Ulm, Germany.
  • Maschmeyer G; Department of Oncology, Hematology, Immunology, Infectious Diseases and Palliative Care, Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany.
  • Kämpfe D; Department of Hematology and Medical Oncology, Universitätsklinikum Jena, Jena, Germany.
  • Kahl C; Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany.
  • Vucinic V; Medical Practice for Hematology and Oncology, Outpatient Chemotherapy and Palliative Care, Lüdenscheid, Germany.
  • Monecke A; Department of Hematology, Oncology and Palliative Care, Klinikum Magdeburg, Magdeburg, Germany.
  • Hirt C; Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany.
  • Weber T; Institute of Pathology, Universitätsklinikum Leipzig, Leipzig, Germany.
  • Meissner J; Department of Hematology and Oncology, Transplantation Centre and Palliative Care, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Witzens-Harig M; Department of Hematology and Oncology, Universitätsklinikum Halle (Saale), Halle (Saale), Germany.
  • Böttcher S; Department of Hematology, Oncology and Rheumatology, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Schmalenberg H; Department of Hematology, Oncology and Rheumatology, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Marks R; Department of Hematology, Oncology and Palliative Care, Universitätsmedizin Rostock, Rostock, Germany.
  • Prange-Krex G; Department of Hematology, Medical Oncology and Palliative Care, Städtisches Klinikum Dresden, Dresden, Germany.
  • Kroschinsky F; Department of Hematology, Oncology and Stem Cell Transplantation, Universitätsklinikum Freiburg, Freiburg, Germany.
  • Hauf E; Onkopraxis Dresden, Dresden, Germany.
  • Keller U; Department of Hematology and Oncology, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Koch K; Department of Hematology and Oncology, Klinikum rechts der Isar der Technischen Universität München, München, Germany.
  • Klapper W; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Herold M; Department of Hematology and Oncology, Klinikum rechts der Isar der Technischen Universität München, München, Germany.
  • Scholz CW; Department of Hematopathology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Ann Hematol ; 99(12): 2821-2829, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32734548
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Antineoplásicos Alquilantes / Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Antineoplásicos Alquilantes / Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha